title: Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.
abstract: Experts now recommend that all Helicobacter pylori infections be eradicated unless there are compelling reasons not to. As with other infectious diseases, effective therapy should be based on susceptibility.
authors.affiliation: Professor, Department of Internal Medicine, Kawasaki Medical School, Okayama, Japan.
authors.forename: Akiko
authors.initials: A
authors.lastname: Shiotani
authors.affiliation: GI Division, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institution of Digestive Disease, Shanghai, China.|Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai, China.|Vice-director of Chinese H pylori Study Group of Chinese Society of Gastroenterology, Shanghai, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Lu
authors.affiliation: GI Fellowship Program Director, Dipartimento di Medicina Clinica e Sperimentale, Clinica Medica, University of Sassari, Sassari, Italy.
authors.forename: Maria Pina
authors.initials: MP
authors.lastname: Dore
authors.affiliation: Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. dgraham@bcm.edu.
authors.forename: David Y
authors.initials: DY
authors.lastname: Graham
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000073602:Antimicrobial Stewardship; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D019936:Probiotics / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D016879:Salvage Therapy
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors